Request for Covid-19 Impact Assessment of this Report
End-user/ Technology
Hospitals, healthcare centers, blood banks and blood collection centers are using this technique to perform a safe blood transfusion. The various processes used for separation are centrifugation, absorption, and filtration. Continous flow centrifugation and intermittent flow centrifugation are two of the techniques used for centrifugation procedure. It has a various application which includes plasma exchange, removal of low-density lipoprotein, removal of malignant white blood cells from patients suffering from leukemia, removal of erythrocytes, and collection of platelets.
Market Dynamics
The global apheresis market is experiencing a high growth rate on account of rising chronic diseases, growing need for plasma and other blood components, growing concerns regarding blood transfusion techniques, complex surgical procedures and technological advancement. On the other hand lack of awareness about apheresis process, the high cost of instruments, and insufficient donors & skilled professionals, and medical regulations are the main restraint for the growth of the industry.
Market Segments
The global apheresis market can be segmented based on product, application, and procedures. It has application in renal diseases, hematology, cancer treatment, cardiovascular diseases and neurological disorder. The various procedures of apheresis include plasmapheresis for collecting fresh frozen plasma, erythrocytapheresis for separating erythrocytes, Plateletpheresis for collecting platelets, and leukapheresis to remove PMNs, basophils, and eosinophils.
Regional/Geographic Analysis
North America is the market leader followed by Europe and Asia Pacific. Technological advancement, venture capital investment, govt support and increasing awareness among blood transfusion ensure North America's leadership in apheresis market. High purchasing power and disposable income in North America and Europe also ensure the market growth. Investors and manufacturers are highly interested in Asia Pacific regions due to the presence of untapped market with lots of opportunities.
Opportunities
Technological advancement, Govt. support and increasing awareness among people are creating lots of opportunities in the current market. Research is going on applying apheresis in the pediatric segment. The highest growth rate is expected to be in the Asia Pacific region in the forecasted period. Various R&D work in critical disease sector and complex surgical procedures are also creating opportunities for the market to grow.
Key Players
Some of the major players in the market include Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), B. Braun Melsungen Ag, Cerus Corporation, Fresenius Se & Co. Kgaa, Haemonetics Corporation, Hemacare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Nikkiso Co., Ltd., Terumo Bct, Inc, Kawasumi Laboratories Inc. (Japan).
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...